Header

UZH-Logo

Maintenance Infos

Vitamin D and outcomes in adult critically ill patients: a systematic review and meta-analysis of randomized trials


Putzu, Alessandro; Belletti, Alessandro; Cassina, Tiziano; Clivio, Sara; Monti, Giacomo; Zangrillo, Alberto; Landoni, Giovanni (2017). Vitamin D and outcomes in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Journal of Critical Care, 38:109-114.

Abstract

PURPOSE Low vitamin D blood levels are associated with high mortality in critically ill patients. There is controversy about vitamin D supplementation in this population. The objective of this meta-analysis was to evaluate if vitamin D administration reduces mortality in critically ill patients. MATERIALS AND METHODS Online databases were searched up to September 1(st), 2016 for randomized placebo-controlled trials on the use of vitamin D in adult patients with critical illness. The primary end point was mortality among trials with low risk of bias. The secondary end points were length of hospital stay, length of intensive care unit stay, length of mechanical ventilation, and adverse events. RESULTS Seven studies published between 2011 and 2016, for a total of 716 patients, were included in the analysis. Vitamin D administration was associated with significantly lower mortality compared with placebo (101/320 [32%] in the vitamin D group vs 123/307 [40%] in the placebo group; odds ratio, 0.70 [95% confidence interval, 0.50 to 0.98]; P=.04; I(2)=0%). No differences in adverse events and other secondary end points were found. CONCLUSIONS In critically ill patients, vitamin D administration might be associated with a reduction in mortality without significant adverse events. A large multicenter randomized trial should conclusively confirm these findings.

Abstract

PURPOSE Low vitamin D blood levels are associated with high mortality in critically ill patients. There is controversy about vitamin D supplementation in this population. The objective of this meta-analysis was to evaluate if vitamin D administration reduces mortality in critically ill patients. MATERIALS AND METHODS Online databases were searched up to September 1(st), 2016 for randomized placebo-controlled trials on the use of vitamin D in adult patients with critical illness. The primary end point was mortality among trials with low risk of bias. The secondary end points were length of hospital stay, length of intensive care unit stay, length of mechanical ventilation, and adverse events. RESULTS Seven studies published between 2011 and 2016, for a total of 716 patients, were included in the analysis. Vitamin D administration was associated with significantly lower mortality compared with placebo (101/320 [32%] in the vitamin D group vs 123/307 [40%] in the placebo group; odds ratio, 0.70 [95% confidence interval, 0.50 to 0.98]; P=.04; I(2)=0%). No differences in adverse events and other secondary end points were found. CONCLUSIONS In critically ill patients, vitamin D administration might be associated with a reduction in mortality without significant adverse events. A large multicenter randomized trial should conclusively confirm these findings.

Statistics

Altmetrics

Downloads

1 download since deposited on 09 Jan 2017
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Cardiocentro Ticino
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2017
Deposited On:09 Jan 2017 09:59
Last Modified:09 Jan 2017 09:59
Publisher:Elsevier
ISSN:0883-9441
Publisher DOI:https://doi.org/10.1016/j.jcrc.2016.10.029
PubMed ID:27883968

Download

Preview Icon on Download
Content: Published Version
Filetype: PDF - Registered users only
Size: 617kB
View at publisher